DBV Technologies (DBVT) Change in Accured Expenses (2020 - 2026)

DBV Technologies (DBVT) reported Change in Accured Expenses of -$4.7 million for Q1 2026, down 51.61% year-over-year from -$9.7 million in Q1 2025, and down 165.46% quarter-over-quarter from $7.2 million in Q4 2025.

DBV Technologies (DBVT) Change in Accured Expenses (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 7 years of Change in Accured Expenses data on file, last reported at -$4.7 million in Q1 2026.

  • Change in Accured Expenses for Q1 2026 came in at -$4.7 million, down 51.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 million (up 377.3% YoY), and the FY2025 annual result was $6.5 million, up 1681.69% from the prior year.
  • Change in Accured Expenses retreated to -$4.7 million in Q1 2026 per DBVT's latest filing, from $7.2 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $7.2 million in Q4 2025 and troughed at -$4.7 million in Q1 2026.
  • A 5-year average of -$176176.5 and a median of $366000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses plunged 178.35% in 2023, then jumped 1463.16% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.6 million in 2022, then sank by 178.35% to -$2.8 million in 2023, then surged by 157.09% to $1.6 million in 2024, then jumped by 351.29% to $7.2 million in 2025, then slumped by 165.46% to -$4.7 million in 2026.
  • Business Quant data shows DBVT's Change in Accured Expenses at -$4.7 million in Q1 2026, $7.2 million in Q4 2025, and $868000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn -4.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.70 Mn
Mar 31, 2026 -4.70 Mn
Dec 31, 2025 7.18 Mn
Dec 31, 2025 7.18 Mn
Sep 30, 2025 868,000.00
Sep 30, 2025 868,000.00
Jun 30, 2025 1.57 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 -3.10 Mn
Mar 31, 2025 -3.10 Mn
Dec 31, 2024 1.59 Mn
Dec 31, 2024 1.59 Mn
Sep 30, 2024 1.35 Mn
Sep 30, 2024 1.35 Mn
Jun 30, 2024 1.19 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 -3.77 Mn
Mar 31, 2024 -3.77 Mn
Dec 31, 2023 -2.79 Mn
Dec 31, 2023 -2.79 Mn